-The Times of India CHENNAI: Many customers only realise at the time of making a claim that their health insurance policy does not cover certain medical conditions or ailment. Policy holders usually depend on what has been told to them by their insurance agents, who sometimes overstate the coverage. To prevent such cases, the Insurance Regulatory and Development Authority of India (IRDAI) has asked insurers to group together all policy exclusions...
More »SEARCH RESULT
The alarming levels of India's groundwater
-The Hindu Leading hydrogeology scientist explains how India’s dependence on groundwater could lead to a crisis if left unchecked Mumbai: Groundwater is the world’s most extracted raw material, supplying and sustaining a range of human activity. Yet, because it is invisible and it’s supply often taken for granted, it is often inadequately acknowledged in policy and debates about the preservation of groundwater commons and aquifers. At best, it is usually shrouded in...
More »Surat Textile Traders on Indefinite Strike Against GST -Damayantee Dhar
-TheWire.in The traders have incurred a loss of over Rs 5000 crore in the last 22 days, while 15 lakh labourers have lost their jobs due to the shutdown. Surat: On July 8, Surat, the economic capital of Gujarat, witnessed an unprecedented protest against the new tax regime, the Goods and Service Tax (GST). Texile traders swarmed a three-km stretch on the Ring Road, which holds city’s main textile market, on a...
More »GST fear: Drug-makers expect shortage of medicines
-The Times of India NEW DELHI: With just a day to go before the roll out of goods and services tax (GST) in India from July 1, the country's drug industry fears that there may be a temporary shortage of medicines as many traders and chemists are yet to comply with the norms. Though the All India Organisation of Chemists and Druggists, which represents over 8 lakh chemists, has assured the government...
More »Flawed drug price rules fleeced patients, helped hospitals -GS Mudur
-The Telegraph New Delhi: India's drug pricing rules allow companies to inflate the maximum retail prices of medicines, including life-saving drugs, costing patients thousands of additional rupees while offering slices of the profits to stockists, chemists, and hospitals. Quotations received by hospitals from drug companies' representatives offering discounts on maximum retail prices (MRPs) of medicines provide what some doctors and patients' rights advocates say is fresh evidence for excessive profiteering in India's...
More »